Capsugel completes $25m SDD expansion at Bend site
Capsugel has pledged to continue investing internally in drug delivery R&D after completing construction of a spray-dried dispersion (SDD) commercial manufacturing site in Oregon.
Archives for July 1, 2015
Small molecule chromatography demand driving expansion, says services firm
UK firm Reach Separations is doubling its lab space as pharma companies call for more chromatography services.
Evotec, Roche announce failure of late-stage Alzheimer’s candidate
In another setback for Alzheimer’s drug developers, European CRO/biotech Evotec and partner Roche have announced that their candidate did not meet its primary endpoint after 52 weeks treatment in a Phase IIb study.
Suspect Viagra pills seized in EU-wide swoop on organised crime gang
More evidence linking fake pharmaceuticals and organised crime emerged today with Dutch police seizing suspicious Viagra pills along with cocaine, MDMA and burglary tools.
Hospira's Vizag plant begins sterile production following US FDA approval
Hospira has begun commercial production at a sterile injectable plant in India hit with several 483 forms after the US FDA deemed the site ‘acceptable.’
PPD forges pediatric investigator network with eight sites
CRO Pharmaceutical Product Development (PPD) has formalized relationships with eight investigator sites to create a pediatric investigator network (PIN) as part of efforts to speed trial startups, more predictably enroll patients and offer higher quality...
Lonza to set up dedicated manufacturing suite for Alexion
Lonza will set up a dedicated manufacturing suite for Alexion, producer of the world’s most expensive drug Soliris.
Allergan targets Actavis legacy plant in Iceland in cost-cutting move
Manufacturing operations at an Actavis legacy site in Iceland will cease and products will be transferred out the country from 2016, Allergan has announced.
Staff cuts and accelerated access: MHRA’s plan for 2016
MHRA, the UK pharma regulator, says its staff cuts over the next three years will not impact its work with pharma.
UK will label drugs with their cost to the state
The UK health minister has announced plans to label all British prescription medicines with their cost to the taxpayer.